News
Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...
When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid ...
GALES FERRY, Conn. (WTNH) — Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% in some Alzheimer’s patients.
MindGlide was 60% better than SAMSEG and 20% better than WMH-SynthSeg for locating brain plaque (or lesion) abnormalities, or for monitoring treatment effects. The results from the study show that ...
When doctors suspect Alzheimer's, they can order a blood test to learn whether a patient's brain contains the sticky amyloid plaques that are a hallmark of the disease. But the results of that ...
New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease. Latest Alzheimer's lab tests focus on memory loss, not brain plaques When doctors suspect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results